Significant Ownership of Merck & Co., Inc.
- Signature - Title
- /s/ Kelly Grez - Kelly Grez/Corporate Secretary
- Location
- Rahway, NJ
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Merck & Co., Inc..
Follow Filing Activity
Follow Merck & Co., Inc. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Merck & Co., Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EVAX | Evaxion Biotech A/S | American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share | 20% | $105,531,938 | 63,004,142 | Merck & Co., Inc. | 31 Jan 2025 | ||
| PSNL | Personalis, Inc. | Common Stock, $0.0001 par value per share | 16% | $53,792,132 | 14,044,943 | Merck & Co., Inc. | 19 Dec 2024 |
Schedules 13D/G Reported by Merck & Co., Inc.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.